• Главная
  • Каталог
  • Стентовые технологии: рынок, история, организация производства
Скачать прайс-лист
Читать онлайн

Стентовые технологии: рынок, история, организация производства

Авторы:
М. А. Масленников, Е. С. Ермолаев
Монография Медицинская техника
Бумажная
Электронная
  • Формат: 165×235
  • Переплёт: мягкий
  • Год издания: 2022 г.
  • Объём: 168 стр.
  • Объём: 12.60 п.л.
  • Номер издания: 1
  • Вес: 218 г.
  • ISBN: 978-5-7038-6004-5
  • Формат: PDF
  • Объём: 168 стр.
  • Год издания: 2022 г.
  • Номер издания: 1
  • ISBN: 978-5-7038-6004-5

О книге

В настоящей книге речь пойдет об истории развития эндоваскулярной хирургии и технологии производства стентов, начиная с постановки научно-технической задачи, и заканчивая юридическими тонкостями организации всего процесса. Впервые будут продемонстрированы этапы проектирования и оптимизации конструкции, создание заготовок, изготовления и обработки заготовок и контроль качества по современным стандартам на примере сосудистого стента, разработанного группой отечественных ученых, инженеров и практикующих врачей-хирургов.

Книга будет интересна инженерам, врачам, студентам и ординаторам, желающим познакомиться с основными принципами современного производства медицинских изделий.
Список литературы
  1. CoumandA. Cardiac catheterization; development of the technique, its contributions to experimental medicine, and its initial applications in man // Acta Med. Scand. Suppl. 1975. 579. Рр. 3-32
  2. Hall W.D. Stephen Hales: theologian, botanist, physiologist, discoverer of hemodynamics // Clinical Cardiology. 1987. 10(8). Рр. 487-489. doi:10.1002/ clc.4960100816.
  3. BuzziA. Claude Bernard and cardiac sounding // Rev Asoc Med Argent. 1959. 73. Рр. 277-281.
  4. Roguin A. Adolf Eugen Fick (1829-1901) -The Man Behind the Cardiac Output Equation // Am. J. Cardiol. 2020. 133. Рр. 162-165. doi: 10.1016/j. amjcard.2020.07.042.
  5. Sen M., HonavarS.G. Wilhelm Conrad Rontgen: Finding X // Indian journal of ophthalmology. 2021. 69(10). Рр. 2570-2572. https://doi.org/10.4103/ijo. IJO_2321_21.
  6. Бехтерев В.М. Летопись научных собраний врачей С.-Петербургской клиники душевных и нервных болезней. Экстренное засдаМе 15 февраля 1896 года // Неврологический вестник. 1897. Т. 5. № 3. С. 1-3.
  7. Wake R., Yoshiyama M., Iida H., Takeshita H., Kusuyama T., Kanamitsu, H., Haze, K. History of Coronary Angiography. Advances in the Diagnosis of Coronary Atherosclerosis. Advances in the Diagnosis of Coronary Atherosclerosis. 2011. Edited by Prof. Suna Kirac. doi:10.5772/22578.
  8. Haschek E. Lindenthal O'F. A contribution to the practical use of the photography according to Rontgen // Wien Klin. Wochenschr. 1896. 9. Рр. 63.
  9. Case J.T. Carlos Heuser, 1878-1934 // The American journal of roentgenology and radium therapy. 1934. 32. Рр. 242.
  10. Forssmann W. Die Sondierung des rechten Herzens // Klinike Wochenschrift. 1929. 8. Рр. 20852087.
  11. Mueller R., Sanborn T. The History of Interventional Cardiology // American Heart Journal. 1995. 129. Рр. 146-172.
  12. Packy L.M., Gross D. Between Cardiology and Urology: Werner Forssmann’s Double Career // Urol. Int. 2019. 103(1). Рр. 1-7. doi:10.1159/000499093.
  13. Sulek K. Nobel prize for Andre F. Cournand. Werner T. O. Forssmann and Dickinson W. Richards in 1956 for the discovery related to heart catheterization and studies on pathological changes in the cardiovascular system // Wiad. Lek. 1969. 22(2). Рр. 203-204.
  14. Бакулев А.Н., Мешалкин Е.Н. Опыт применения контрастной ангиокардиографии в грудной хирургии // Вестник хирургии им. И. И. Грекова. 1951. Т. 71. № 4. С. 66.
  15. Мешалкин Е.Н. Демонстрация контрастных ангиокардиограмм трех больных в Московском хирургическом обществе 8 декабря 1950 г. // Хирургия. 1951. № 5. С. 93-94.
  16. Мешалкин E.H. Ангиокардиография у больных с ВПС. Дисс... док. мед. наук. Москва, 1953.
  17. Seldinger S.I. Catheter replacement of the needle in percutaneous arteriography; a new technique // Acta radiologica. 1953. 39(5). Рр. 368376. doi: 10.3109/00016925309136722.
  18. Proudfit W.L. In memoriam F. Mason Sones, Jr., M.D. (1918-1985): the man and his work // Cleve Clin Q. 1986. 53(2). Рр. 121-124. doi:10.3949/ccjm.53.2.121.
  19. Sones F.M.Jr., Shirey E.K, Proudfit W.L., Westcott R.N. Cine-coronary arteriography (abstract) // Circulation. 1959. 20. Рр. 773-774.
  20. Леонид Симонович Зингерман (к 85-летию со дня рождения) // Неотложная медицинская помощь. Журнал им. Н.В. Склифосовского. 2012. № 3. С. 77-79.
  21. Петросян Ю.С., Зингерман Л.С. Коронарография. Москва: Медицина, 1974.
  22. .DotterC.T., Judkins M.P.Transluminaltreatment of arteriosclerotic obstruction. Description of a new technic and a preliminary report of its application // Circulation. 1964. 30. Рр. 654-670. doi: 10.1161/01. cir.30.5.654.
  23. Payne M.M. Charles Theodore Dotter. The father of intervention // Tex. Heart Inst. J. 2001. 28(1). Рр. 28-38.
  24. Judkins M.P. Selective Coronary Arteriography // Radiology. 1967. 89(5). Рр. 815-824. doi:10.1148/89.5.815
  25. .ZeitlerE.,Schoop W.,Zahnow W.The treatment of occlusive arterial disease by transluminal catheter angioplasty // Radiology. 1971. 99(1). Рр. 19-26. doi: 10.1148/99.1.19.
  26. Gruntzig A. Transluminal dilatation of coronary-artery stenosis // Lancet. 1978. 1. Рр. 263.
  27. .Bernhard M. The First Patient to Undergo Coronary Angioplasty — 23-Year Follow-up // New England Journal of Medicine. 2001. 344(2). Рр. 144145. doi:10.1056/N EJM200101113440217.
  28. Gruentzig A., Turma M., Schneider J. Experimental percutaneous dilatation of coronary artery stenosis // Circulation. 1976. 54. Suppl. 81.
  29. Gruentzig A.R., Myler R.K., Hanna E.S., Turina M.I. Coronary transluminal angioplasty // Circulation. 1977. 84. Рр. 55-56.
  30. Gruentzig A.R., Senning A., Siegenthaler W.E. Nonoperative dilataoin of coronary-artery stenosis // N. Engl. J. Med. 1979. 301. Рр. 61-68.
  31. Abele J.E. Balloon catheters and transluminal dilatation: technical considerations // Am. J. Roentgenol. 1980. 135(5). 901-6. doi: 10.2214/ajr.135.5.901.
  32. .Stertzer S.H., Myler R.K., Bruno M., Wallsh E. Transluminal Coronary Artery Dilatation // Prac. Cardiol. 1979. 5(3). Рр. 25.
  33. Gaspard P., Whitin H. The History of Coronary Angioplasty. Toulouse: Europa digital & publishing, 2017.
  34. Rentrop K.P., Feit F. Reperfusion therapy for acute myocardial infarction: Concepts and controversies from inception to acceptance // Am. Heart. J. 2015. 170(5). Рр. 971-980. doi: 10.1016/j. ahj.2015.08.005.
  35. Willerson J.T. In Memoriam: Geoffrey O. Hartzler (1946-2012) // Texas Heart Institute Journal. 2012. 39. Рр. 317-318.
  36. Simpson J.B., Robert N., Baim D., Harrison D.C. Clinical experience with a new catheter system for percutaneous transluminal coronary angioplasty (abstract) // Am. J. Cardiol. 1981. 4. Рр. 395.
  37. Коваленко И.Б. Судакова М.В., Жернако-ва Н.И. Эндоваскулярное лечение пациентов с заболеваниями сердечно-сосудистой системы: этапы развития, проблемы и пути их решения // Научные ведомости БелГУ. Серия Медицина. Фармация. 2011. Т. 99. № 4. С. 24-29.
  38. Ellis S.G. Kereiakes D.J., Metzger D.C. et al. ABSORB III Investigators. Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease // N. Engl. J. Med. 2015. 373(20). Рр. 1905-1915.
  39. .Gao, R., Yang Y., Han Y., Huo Y. et al. ABSORB China Investigators. Bioresorbable Vascular Scaffolds Versus Metallic Stents in Patients with Coronary Artery Disease: ABSORB China Trial // J. Am. Coll. Cardiol. 2015. 66(21). Рр. 2298-2309.
  40. Klomp M., Beijk M.A., Tijssen J.G., de Winter R.J. One-year clinical outcome in an unselected patient population treated with the Genous endothelial progenitor cell capturing stent // Catheter Cardiovasc. Interv. 2011. 77(6). Рр. 809-817.
  41. Dangoisse V., Val P.G., David P.R., Lesperance J. et al. Recurrence of stenosis after successful percutaneous transluminal coronary angioplasty PTCA. (abstract) // Circulation. 1982. 66(Suppl II). II-331.
  42. Guiteras V., Bourassa M.G., David P.R. et al. Restenosis after percutaneous transluminal coronary angioplasty: the Montreal Heart Institute experience // Am. J. Cardiol. 1987. 60. 50B.
  43. Leimgruber P.P., Roubin G.S., Hollman J. Restenosis after successful coronary angioplasty inpatients withsingle vessel disease // Circulation. 1986. 73. Рр. 710-717.
  44. Nobuyoshi M., Kimura T., Nosaka H. et al. Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients // J. Am. Coll. Cardiol. 1988. 12(3). Рр. 616-623.
  45. Cowley M.J., Dorros G., KelseyS.F. et al. Acute coronary events associated with percutaneous transluminal coronary angioplasty // Am. J. Cardiol. 1984. 53. Рр. 12С-16С.
  46. Detre K., Holubkov R., Kelsey S. et al. Percutaneous transluminal coronary angioplasty in 1985-1986 and 1977-1981. The National Heart, Lung, and Blood Institute Registry // N. Engl. J. Med. 1988. 318(5). Рр. 265- 270.
  47. Faxon D.P., Sanborn T.A., Weber V.J. et al. Restenosis following transluminal angioplasty in experimental atherosclerosis // Arteriosclerosis. 1984. 4. Рр. 189-195.
  48. Gruentzig A.R., King S.B., Schlumpf M., Siegenthaler W. Long-term follow-up after percutaneous transluminal coronary angioplasty. The early Zurich experience // N. Engl. J. Med. 1987. 316(18). Рр. 1127-1132.
  49. Kuntz R.E., Gibson C.M., Nobuoshi M., Baim D.S. Generalized model of restenosis after conventional balloon angioplasty, stenting and directional aterectomy // J. Am. Coll. Cardiol. 1993. 21. Рр. 15-25.
  50. LincoffA.M., Popma J.J., EllisS.G., Hacker J.A., Topol E.J. et al. Abrupt vessel closer complicating coronary angioplasty: clinical, angiografic and therapeutic profile // J. Am. Coll. Cardiol. 1992. 19. Рр. 926-935.
  51. Савченко А.П., Руденко Б.А. Клиническая эффективность эндоваскулярных технологий при лечении ишемической болезни сердца // Кардиологический вестник. 2008. Т. 3. № 1. С. 5-11.
  52. Fishman D.L., Leon M.B., Baim D.S. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease // N. Engl. J. Med. 1994. 331. Рр. 496-501.
  53. Serruys P., de Jaegere P., Kiemeneij F., Macaya C. et al. A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary artery disease. (BENESTENT) // The new England journal of medicine 1994. 8. Рр. 489495.
  54. Di Mario C., Moses J., Anderson T. Multicenter randomized comparison of early clinical events after primary stenting or balloon angioplasty in 619 patients (abstr) // Circulation. 1998. 98 (Suppl. I): I-228.
  55. Serruys P.W., de Feyter P.J., de Jaegere P.P., Macleod D.C., Foley D. Interventional techniques for management of coronary artery lesions // The Clin. Cardiol. Journal. 1993. 8. Рр. 586-593.
  56. Serruys P.W., Kay I.P., Disco C., Deshpande N.V., de Feyter P.J. Periprocedural quantitative coronary angiography after Palmaz-Schatz stent implantation predicts the restenosis rate at six months: Results of a metaanalysis of the belgian netherlands stent study (BENESTENT) I, BENESTENT II pilot, BENESTENT II and MUSIC trials // J. Am. Coll. Cardiol. 1999. 34. Рр. 1067-1074.
  57. TilliF.V., AliabadiD., Kinn J.W. Real life stenting: a comparison of target vessel revascularization in BENESTENT-STRESS lesions to non-BENESTENT-STRESS lesion (abstr) // Circulation. 1996. 94 (Suppl. I). I-332.
  58. Sawada Y., Nosaka H., Kimura T. et al. Initial and six-month outcome of Ralmaz-Schatz stent implantation: STRESS/BENESTENT equivalent versus nonequivalent lesions // J. Am. Coll. Cardiol. 1996. 27 (suppl. A). Рр. 252A.
  59. Шевченко Ю.Л., Карпов О.Э. Стентовая хирургия. Москва: ДПК Пресс, 2020.
  60. Петровский Б.В., Полухин П.И., Рабкин И.Х. и др. Авторское свидетельство № 1342511 «Способ внутрисосудистой установки протеза». Приоритет от 1 августа 1984 г.
  61. Рабкин И.Х., Займовский В.А., Хмелев-ская И.Ю., Максимович И.В., Рабкин Д.И., Хасе-пов Б.П. Экспериментальное обоснование и первый клинический опыт рентгеноэндоваску-лярного протезирования. // Вестник рентгенологии и радиологии. 1984. Т. 4. С.59-64.
  62. Рабкин И.Х. Начало эпохи стентов (задумка, намерения, осуществление нетинолового стентирования) // Диагностическая и интервенционная радиология. 2008. Т. 2. № 2. С. 5-15.
  63. Самко А.Н., Савченко А.П. Некоторые современные направления чреспросветной коронарной ангиопластики // Кардиология. 1993. № 9. C. 62-67.
  64. Володось Н.Л., Шеханин В.Е., Карпович И.П., Троян В.И., Гурьев Ю.А. Самофиксирующийся синтетический протез для эндопротезирования сосудов // Вестник хирургии. 1986. Т. 137. № 11. С. 123-125.
  65. SvetlikovA.V. Unknown pages in the blistery of vascular stent grafting // J. Vasc. Surg. 2014. Vol. 59. Рр. 865-868.
  66. Parodi J.C., Palmaz J.C., Barone H.D. Transfemoral intraluminal graft implantation for abdominal aortic aneurysms // Ann. Vasc. Surg. 1991.5(6) Рр. 491-499.
  67. Хубулава Г.Г., Светликов А.В. Николай Леонтьевич Володось. История неоспоримого мирового приоритета в изобретении сосудистого эндопротеза. // Вестник хирургии. 2017. Т. 176. № 3. С. 95-98.
  68. Bjorck M. The fall of a giant professor Nicolai Leontyevich Volodos. May 15, 1934-April 3, 2016 // Eur. J. Vasc. Endovasc. Surg. 2016. 52(1). Рр.3-4.
  69. Roguin A. Stent: the man and word behind the coronary metal prosthesis // Circulation: Cardiovascular Interventions. 2011. 4(2). Рр. 206-209. doi:10.1161/CI RCINTERVENTIONS.110.960872.
  70. Sigwart U., Puel J., MirKovitch V. et al. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty // N. Engl. J. Med. 1987. 316. Рр. 701-706.
  71. Sigwart U., Urban P., Golf S. et al. Emergency stenting for acute occlusion after coronary balloon angioplasty // Circulation. 1988. 78. Рр. 121-127.
  72. .Serruys P.W., Emanuelsson H., van der Giessen W. et al. Heparincoated Palmaz-Schatz stents in human coronary arteries: Early out-come of the BENESTENT II Pilot Study // Circulation. 1996. 93. Рр. 412-422.
  73. PalmazJ.C,SibbittR.R, ReuterS.R, TioFO, Rice W.J. Expandable intraluminal graft: a preliminary study. Work in progress // Radiology. 1985 Jul.156(1). Рр. 73-77. doi: 10.1148/radiology.156.1.3159043.
  74. Tan C., Schatz R.A. The History of Coronary Stenting // Interv. Cardiol. Clin. 2016. Jul. 5(3). Рр. 271-280. doi: 10.1016/j.iccl.2016.03.001.
  75. Roubin G.S. The First Balloon-Expandable Coronary Stent: An Expedition That Changed Cardiovascular Medicine. Hardcover, 2015.
  76. Roubin G.S., Robinson K.A., King S.B. III et al. Early and late results of intracoronary arterial stenting after coronary angioplasty in dogs // Circulation. 1987. 76(4). Рр. 891-897.
  77. Vrints C.J., Cools F., Bosmans J., Claeys M., Snoeck J.P. Acute Luminal Gain after Stenting: Comparison of Gianturco- Roubin and Palmaz-Schatz Stents // J. Invasive Cardiol. 1996. 8(3). Рр. 135-143.
  78. Габбасов З.А., Козлов С.Г. Клеточные аспекты патогенеза стенозирования артерий и рестеноза стентов // Клиническая геронтология. 2009. Т. 15. № 3. С. 3-9.
  79. Faxon D.P., Williams D.O., Yeh W. et al. Improved in-hospital outcome with expanded use of coronary stents: results from the NHLBI dynamic registry // J. Am. Coll. Cardiol. 1999. 33(Suppl. A). 91A.
  80. Hoffmann R., Mintz G.S. Coronary in-stent restenosis - predictors, treatment and prevention // Eur. Heart J. 2000. 21(21). Рр. 1739-1749.
  81. Al Suwaidi J., Berger P., Holmes D.R. Coronary artery stents. JAMA. 2000. 284. Рр. 1828-1836.
  82. Goldberg S.L., Loussararian A., Gregorio J. De, di Mario C., Albiero R., Colombo A. Predictors of diffuse and aggressive intrastent restenosis // J. Am. Coll. Cardiol. 2001. 37. Рр. 1019-1025.
  83. Kume T., Akasaka T., Kawamoto T., Okura H., Watanabe N., Toyota E. et al. Measurement of the thickness of the fibrous cap by optical coherence tomography // Am. Heart J. 2006. 152(4). 755.e1-4.
  84. Мойлян Д.Э., Афоносьев Ю.И., Гогорно Д.О. Современное состояние проблемы in-stent рестенозов // Научные ведомости БелГУ Серия Медицина. Фармация. 2015. Т. 207. № 10. Вып. 30. С. 5-12.
  85. Joner M., Finn A.V., Farb A., Mont E.K. et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk // J. Am. Coll. Cardiol. 2006. 48(1). Рр. 193-202.
  86. Kandzari D.E., Tuttle R.H, Zidar J.P., Jollis J.G. Comparison of long-term (seven year) outcomes among patients undergoing percutaneous coronary revascularization with versus without stenting // Am. J. Cardiol. 2006. 97(10). Рр. 1467-1472.
  87. Sercelik A., Batyraliev T.A., Samko A.N. et al. In-stent restenosis after placement of various coronary stent types. Материалы 1-го Российского съезда интервенционных кардиоангиологов. Москва, 2002. 4-6 марта. С. 83-84.
  88. Vaknin-Assa H., Assali A., Lev E. et al. Characterization and clinical outcomes of drug-eluting in- stent restenosis // Isr. Med. Assoc. J. 2010. 12(5). Рр. 273-276.
  89. Grube E. Drug eluting stents: a new era in the stent technology // Cardiol. Int. 2001. 2. Рр. 5-6.
  90. Grube E., Sonoda S., Ikeno F. et al. Six- and twelve-month results from first human experience using everolimus-eluting stents with bioabsorbable polymer // Circulation. 2004. 109(18). Рр. 2268-2171.
  91. Baber U., Mehan R., Sharma S.K., Brar S. et al. Impact of the everolimus-eluting stent on stent thrombosis: a meta- analysis of 13 randomized trials // J. Am. Coll. Cardiol. 2011. 58(15). Рр.1569-1577.
  92. Fajadet J., Morice M.C., Bode C. et al. Maintenance of long-term clinical benefit with sirolimus-eluting coronary stent: three-year results of the RAVEL trial // Circulation. 2005.111(8). Рр. 10401044.
  93. Fajadet J., Wijns W., Laarman G.J., Bonan R., Kuntz R.E. Randomized, double-blind, multi- center study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions. Clinical and angiographic results of the ENDEAVOR II Trial // Minerva Cardioangiol. 2007. 55(1). Рр. 1-18.
  94. Meredith I.T., Ormiston J., Whitbourn R., Kay I.P. et al. First-in-human study of the Endeavor ABT-578-eluting phosphorylcholine-encapsulated stend system in de novo native coronary artery lesions: Endeavor I Trial // Eurointervention. 2005. 1(2). Рр. 157-164.
  95. Stone G.W., MideiM., Newman W. et al. SPIRIT III Investigators. Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial // JAMA. 2008. 299(16). Рр. 1903-1913.
  96. Gregory C.R., Huie P., Billinghan M.E., Morris R.E. Rapamycin inhibits arterial intimal thickening caused by both alloimmune and mechanical injury. Its effect on cellular, growth factor, and cytokine response in injured vessels // Transplantation. 1993. 55. Рр. 14091418. doi:10.1097/00007890-199306000-00037.
  97. Gallo R., Padurean A., Jayaraman T. et al. Inhibition of intimai thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle // Circulation. 1999. 99(2). Рр. 21642170.
  98. Jayaraman T., Marks A.R. Repamycin-FKBP12 blocks proliferation, indue differentiation, and inhibits cyc-2 kinase activity in a myogenic cell line // J. Biol. Chem. 1993. 268. Рр. 2538-2588.
  99. Suzuki T., Kopia G., Hayashi S. et al. Stent-based dlivery of sirolimus reduces neointimal formation in a porcine coronary model. // Circulation. 2001. 104. Рр. 1188-1193.
  100. Sousa J.E., Costa M.A., Abizaid A. et al. Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up // Circulation. 2001. 104. Рр. 2007-2011.
  101. Sousa J.E., Costa M.A., Abizaid A. et al. Lack of neointimal proliferation* after implantation of sirolimus-coated stents in human coronary arteries // Circulation. 2001. 103. Рр. 192-195.
  102. Colombo A., Fajadet J., Schuler G. 365-day follow-up of the RAVEL study: a randomized study with sirolimus-eluting BX Velocity balloon-expandable stent // Eur. Heart J. 2002. 4(Suppl. A). Рр. 264.
  103. Ako J., Morino Y., Honda Y. et al. Late incomplete stent apposition following sirolimus eluting stent: serial quantitative intravascular ultrasound analysis from the SIRIUS trial // J. Am. Coll. Cardiol. 2003. 41(Suppl. A). 33A.
  104. Cohen D.J., Bakhai A., Shi C. et al. Cost-effectiveness of sirolimus drugeluting stents for the treatment of complex coronary stenoses: results from the randomized SIRIUS tria //. J. Am. Coll. Cardiol. 2003. 41(Suppl. A). 32A.
  105. Leon M.B., Moses J.W., Weisz G. et al. The frequency and consequences of angiographic aneurysms after sirolimus-eluting stents: results from SIRIUS // J. Am. Coll. Cardiol. 2003. 41(Suppl. A). Рр. 13 A.
  106. Leon M.B., Popma J.J., YakubovS. et al. The effects of sirolimus-eluting stents on in-stent and peri-stent restenosis: an angiographic subanalysis from the SIRIUS trial // J. Am. Coll. Cardiol. 2003. 41(Suppl. A). Рр. 14A.
  107. Weisz G., Leon M.B., Holmes D.R. et al. Five-year follow-up after sirolimus-eluting stent implantation results of the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native Coronary Lesions) Trial // J. Am. Coll. Cardiol. 2009. 53(17). Рр. 1488-1497.
  108. Moses J.W., Leon M.B., Popma J.J. et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery // N. Engl. J. Med. 2003. 349. Рр. 1315-1323.
  109. Lowe H.C., Oesterle S.N., Khachigian L.M. Coronary in-stent restenosis: Current status and future strategies // J. Am. Coll. Cardioll. 2002. 39. Рр. l83-193.
  110. Hong M., Kornowski R., Bramwell O. et al. Paclitaxel-coated Gianturco-Roubin II (GRII) stents reduce neointimal hyperplasia in a porcine coronary in-stent restenosis model // Coron. Artery Dis. 2001. 12(6) Рр. 513-515.
  111. Doi H., Maehara A., Mintz G.S., Yu A. et al. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials //JACC Cardiovasc. Interv. 2009. 2(12). Рр. 1269-1275.
  112. Ellis S.G., O'Shaughnessy C.D., Martin S.L., Kent K., McGarry T. et al. Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent restenosis: the TAXUS V ISR trial // Eur. Heart J. 2008. 29(13). Рр. 1625-1634.
  113. Grube E., Silber S., Hauptmann K.E. et al. TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions // Circulation. 2003. 107(1). Рр. 38-42.
  114. Tanabe K., Serruys P.W., Grube E., Smits P.C., Selbach G. et al. TAXUS III Trial: in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation // Circulation. 2003. 107(4). Рр. 559-564.
  115. Turco M.A., Ormiston J.A., Popma J.J., et al. Polymer-based, paclitaxel-eluting TAXUS Libert6 stent in de novo lesions: The pivotal TAXUS ATLAS trial // J. Am. Coll. Cardiol. 2007. 49(16). Рр. 1676-1683.
  116. Веселовская Н.Г., Чумакова Г.А., Суворова А.А. Прогнозирование риска рестеноза коронарных артерий после их стентирования у пациентов с ожирением // Сердце. 2013. Т. 12. № 5. С. 305-310.
  117. Ярбекова Р.Р., Чегогидзе Н.А., Сигаев И.Ю. Ближайшая и отдаленная эффективность чрескожного коронарного вмешательства у больных ИБС с многососудистым поражением коронарных артерий и сахарным диабетом II типа // Анналы хирургии. 2014. № 5. С. 21-26.
  118. Sosnowski C. Second-generation everolimus-eluting and paclitaxel-eluting stents in real life practice (COMPARE): a randomised trial // Kardiol. Pol. 2010. 68(4). Рр. 493-496.
  119. Kedhi E., Joesoef K.S., McFadden E. et al. Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial // Lancet. 2010. 375(9710). Рр. 201-209.
  120. Kandzari D., Mauri L., Popma J.J. et al. Late-term clinical outcomes with zzotarolimus- and sirolimus- eluting stents. 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions) // JACC Cardiovasc. Interv. 2011. 4(5). Рр. 543-550.
  121. Stone G.W., Rizvi A., Newman W. et al. Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease // N. Engl. J. Med. 2010. 362(18). Рр. 1663-1674.
  122. Kirtane A., Leon M.B., Ball M.W., Bajwa H.S. et al. The «final» 5-year follow-up from the ENDEAVOR IV trial comparing a zotarolimus-eluting stent with a paclitaxel-eluting stent // JACC Cardiovasc. Interv. 2013. 6(4). Рр. 325-333.
  123. Gonzalo N., Garcia-Garcia H.M., Serruys P.W., Commissaris K.H. et al. Reproducibility of quantitative optical coherence tomography for stent analysis // EuroIntervention. 2009. 5(2). Рр. 224-232.
  124. Yeh R.W., Silber S., Chen L., Chen S., Hire math S. et al. 5-Year Safety and Efficacy of Resolute Zotarolimus-Eluting Stent: The RESOLUTE Global Clinical Trial Program // JACC Cardiovasc. Interv. 2017. 10(3). Рр. 247-254.
  125. Hwang C.W., Wu D., Edelman E.R. Stent-based delivery is associated with marked spatial variations in drug distribution // J. Am. Coll. Cardiol. 2001. 37 Рр. 1A.
  126. Ormiston J. Bioabsorbable drug-eluting stents // EuroPCR 2010. 17th-20th May 2010. Paris.
  127. Tamai H., Igaki K., Kyo E., Kosuga K., Kawashima A., Matsui S. et al. Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans // Circulation. 2000. 102(4). Рр. 399-404. doi:10.1161/01.CI R.102.4.399.
  128. Nishio S., Kosuga K., Igaki K., Okada M., Kyo E., Tsuji T. et al. Long-term (>10 Years) clinical outcomes of first-in-human biodegradable poly-l-lactic acid coronary stents: Igaki-Tamai stents // Circulation. 2012. 125(19). Рр. 2343-2352. doi: 10.1161/ CIRCULATIONAHA.110.000901.
  129. Erbel R., Di Mario C., Bartunek J. et al. Temporary scaffolding of coronary arteries with bioabsorbable magnesium stent: a prospective, non-randomized multicenter trial // Lancet. 2007. 369. Рр. 1869-1875.
  130. . Zhang Y., Bourantas C.V., Farooq V., Mura-matsu T., Diletti R., Onuma Y., Garcia-Garcia H.M., Serruys P.W. Bioresorbable scaffolds in the treatment of coronary artery disease // Med. Devices (Auckl). 2013. Mar. 12. 6. Рр. 37-48. doi: 10.2147/M DER. S22547.
  131. Кузнецова И.Э., Церетели Н.В., Сухору-ков О.Е., Асадов Д.А. Перспективы применения биодеградируемых стентов в лечении атеросклеротических заболеваний сосудов (обзор данных литературы) // Международный журнал интервенционной кардиоангиологии. 2013. № 32. С.51-56.
  132. Cheng A. Biodegradable Implants. In book: Pediatric and Congenital Cardiology, Cardiac Surgery and Intensive Care Pp.1219-1235) Chapter 68. Springer Editors: Eduardo M. da Cruz, Dunbar Ivy, James Jaggers DOI:10.1007/978-1-4471-4619-3_128.
  133. Serruys P.W., Ormiston J., Onuma Y et al. Absorb trial first-in-man evaluation of a bioabsobable everolimus- eluting coronary stent system: two-year outcomes and results from multiple imaging modalities // Lancet. 2009. 373. Рр. 897-910.
  134. Serruys P. W., Onuma Y., Ormiston J. A. et al. Evaluation of the second generation of a bioresorbable drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis // Circulation. 2010. Vol. 122. Pр. 2301-2312.
  135. Gard S., Serruys P. W. Coronary stents. Looking forward // JACC. 2010. 56(10). Рр. 60-66.
  136. . Welt F., Rogers C. Inflammation and restenosis in the stent area // Aterioscler. Thromb. Vase. Biol. 2002. 22. Рр. 1-8.
  137. Fefat R., Chronos N., Matsumoto D. Fully bioabsorbable salicylate-based sirolimus-eluting stent: Evaluation of stent degradation by optical coherence tomography: [Доклад] // EuroPCR 2010. 17th-20th May 2010. Paris.
  138. Kimura T., Kaburagi S., Tamura T. et al. Remodeling responses of human coronary arteries undergoing coronary angioplasty and atherectomy // Circulation. 1997. 96. Рр. 475-483.
  139. Serruys P. W., Luijten H. E., Beatt K. J. et al. Incidence of restenosis after successful coronary angioplasty: a time- related phenomenon // Circulation. 1988. 77. Рр. 361-371.
  140. Wenaweser P., Daemen J., Zwahlen M. et al. Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice: 4-year results from a large 2-institutional cohort study // J. Am. Coll. Cardiol. 2008. 52. Рр. 1134-1140.
  141. Bittl J.A. Bioresorbable stent: the next revolution // Circulation. 2010. 122. Рр. 2236-2238.
  142. Grube E., Hauptmann K.E., Buellesfeld L., Lim V., Abizaid A. Six-month results of a randomized study to evaluate safety and efficacy of a Biolimus A9 eluting stent with a biodegradable polymer coating // EuroIntervention. 2005. 1(1). Рр. 53-57.
  143. Luthra S., Leiva-Juarez M.M., Taggart D.P. Systematic Review of Therapies for Stable Coronary Artery Disease in Diabetic Patients // Ann. Thorac. Surg. 2015. 100(6). Рр. 2383-2397.
  144. Chevalier В., Silber S., Park S.J. et al. Randomized comparison of the Nobori Biolimus A9-eluting coronary stent with the Taxus Liberte paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the NOBORI trial--Phase 2 // Circ. Cardiovasc. Interv. 2009. 2(3). Рр. 188-195.
  145. Grube E., Buellesfeld L. One year clinical outcomes in patients with acute myocardial infarction treated with a new generation DES: NOBORI AMI study Manchester Royal Infirmary, Manchester, United Kingdom. Presented at Euro PCR-2010, Paris, France; Grube, E. BioMatrix Biolimus A9-eluting coronary stent: a next-generation drug-eluting stent for coronary artery disease // Expert Rev. Med. Devices. 2006. 3(6). Рр. 731-741.
  146. Koh Tian Hai, Serruys P. et al. National Heart Centre, Singa-pore. BEACON Registry: An All-Comers Trial of the Biolimus A9-Eluting Stent. Presented at Angioplasty Summit-TCT Asia Pacific 2006 Serruys, P. LEADERS: 3-Year Follow-up from a Prospective. Randomized Trial of Eiolimus A9-Eluting Stents with a Bioabsorbable Polymer Vs. Sirolimus-Eluting Stents with a durable polymer // Am. Coll. Cardiol. 2010. 56. Рр. B9.
  147. Stefanini G.G., Kalesan B., Serruys P.W. et al. Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial // Lancet. 2011. 378(9807). Рр. 1940-1948.
  148. Weisz G., Leon M.B., Holmes D.R. et al. After Sirolimus-Eluting Stent Implantation. Results of the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native Coronary Lesions) // J. Am. Coll. Cardiol. 2009. 53. Рр. 1488-1497.
  149. Grube E., Buellesfeld L. BioMatrix Biolimus A9-eluting coronary stent: a next-generation drug-eluting stent for coronary artery disease // Expert Rev. Med. Devices. 2006. 3(6). Рр. 731-741.
  150. Tsuchiya Y., LanskyA.J., Costa R.A., Mehran R. et al. Effect of everolimus-eluting stents in different vessel sizes (from the pooled FUTURE I and II trials) // Am. J. Cardiol. 2006. 98(4). Рр. 464-469.
  151. Grube E. Safety and Performance Evaluation of Biosensors Biolimus A9TM Eluting Stent BioMatrixTM) STEALTH I: a 4-year safety follow-up, e-poster, TCT 2008.
  152. Serruys P. LEADERS: 3-Year Follow-up from a Prospective. Randomized Trial of Eiolimus A9-Eluting Stents with a Bioabsorbable Polymer Vs. Sirolimus-Eluting Stents with a durable polymer //
  153. Wykrzykowska J.J., Garg S., Girasis C., de Vries T. et al. Value of the SYNTAX score for risk
  154. assessment in the all-comers population of the randomized multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) trial // J. Am. Coll. Cardiol. 2010. 56(4). Рр. 272-277.
  155. Fath-OrdoubadiF.One year clinical outcomes in patients with acute myocardial infarction treated with a new generation DES: NOBORI AMI study Manchester Royal Infirmary, Manchester, United Kingdom. Presented at Euro PCR-2010, Paris, France.
  156. Stoeckel D. A survey of stent designs // Min. Invas. Ther. & Allied. Technol. 2002. 11 (4). Pp.137-147.
  157. Kim D.B., Choi H, Joo S.M., Kim H.K., Shin J.H., Hwang M.H., Choi J., Kim D.G., Lee K.H., Lim C.H., Yoo S.K., Lee H.M., Sun K. A Comparative Reliability and Performance Study of Different Stent Designs in Terms of Mechanical Properties: Foreshortening, Recoil, Radial Force, and Flexibility // Artificial Organs. 2013. 37(4). Pp. 368-379. https://doi.org/10.1111/aor.12001
  158. Hanawa T. Materials for metallic stents // J. Artif. Organs. 2009. 12. Рр. 73-79.
  159. Папиров И.И., Шкуропатенко В.А., Шокуров В.С., Пикалов А.И. Материалы медицинских стентов: Обзор. 2010. Харьков: НН77Ц ХФТИб.
  160. Tomizawa Y., Hanawa T., Kuroda D., Nishida H., Endo M. Corrosion of stainless steel sternal wire after long-term implantation // J. Artif. Organs. 2006. 9 (1). Рр. 61-66. doi: 10.1007/s10047-005-0321-0
  161. Heintz C., Riepe G., Birken L. etal. Corroded nitinol wires in explanted aortic endografts: an important mechanism of failure? // J. Endovasc. Ther. 2001. 8 (3). Pp. 248-253. doi: 10.1177/152660280100800303
  162. ErbelR., DiMario C., BartunekJ. et al. Temporary scaffolding of coronary arteries with bioabsorbable magnesium stent: a prospective, non-randomized multicenter trial // Lancet. 2007. 369. Pp. 1869-1875.
  163. Zhang J., Li H., Wang W. et al. The degradation and transport mechanism of a Mg-Nd-Zn-Zr stent in rabbit common carotid artery: A 20-month study // Acta Biomater. 2018. 69. Pp. 372-384. doi: 10.1016/j. actbio.2018.01.018
  164. Linardon C. Precision Tube Drawing for Biomedical Applications: Theoretical, Numerical and Experimental Study // These, Docteur De L'universite De Grenoble, 7 aoQt 2006.
  165. Yoshida K., Furuya H. Mandrel drawing and plug drawing of shape-memoryalloy fine tubes used in catheters and stents // Journal of Materials Processing Technology. 2004. Pp. 153-154, 145-150.
  166. Nakamura S., Yoshida M., Nishimoto A. Frictionnal characteristics of coated steel sheets // In Proceedings of the 15th Biennial Congress of the IDDRG. 1988.
  167. 12. Kosano J., Lenard J., Uhrig J., Wallfarth B. The effect of lubricant additives on the coefficient of friction in the flat-die test // Materials Science and Engineering. 2006. A 427. Pp. 274-281. https://doi. org/10.1016/j.msea.2006.04.090
  168. Szakaly E. D., Lenard J. G. The effect of process and material parameters on the coefficient of friction in the flat-die test // Journal of Materials Processing Technology. 2010. 210. Pp. 868-876. doi:10.1016/j. jmatprotec.2010.01.019
  169. Taylor G., Quinney H. The latent energy remaining in a metal after cold working // Proceedings of the Royal Society. 1933. A. 143. Pp. 307-326.
  170. Vernotte P. Calcul numerique, calcul physique: Application a la thermo-cinetique. Technical report. Publications scientifiques et techniques du miinstere de l'air. 1956.
  171. Vega C., Haddi A., Imad A. Investigation of process parameters effect on the copper-wire drawing // Materials and design. 2009. 30. Pp. 33083312. https://doi.org/10.1016/j.matdes.2008.12.006
  172. Shinohara T., Yoshida K. Deformation analysis of surface flaws in stainless steel wire drawing // Journal of Materials Processing Technology. 2005. 162-163. Pp. 579584. https://doi.org/10.1016/j.jmatprotec.2005.02.125
  173. Gervaso F., Capelli C., Petrini L. et al. On the effects of different strategies in modelling balloon-expandable stenting by means of finite element method // J. Biomech. 2008. 41. Pp. 1206-1212. doi: 10.1016/j.jbiomech.2008.01.027
  174. Schiavone A., Zhao L.G. A study of balloon type, system constraint and artery constitutive model used in finite element simulation of stent deployment // Mech. Adv. Mater. Mod. Process. 2015.1. doi: https://doi.org/10.1186/s40759-014-0002-x
  175. Lau K., Mak K., Hung J., Sigwart U. Clinical impact of stent construction and design in percutaneous coronary intervention // Am Heart J. 2004. 147. Pp. 764-773. doi: 10.1016/j.ahj.2003.12.007
  176. Carrozza J.P., Susanne E.H., David J.C. Invivo assessment of stent expansion and recoil in normal porcine coronary arteries // Circulation 100. 1999. Pp. 756-760. https://doi.org/10.1161/01.CIR.100.7.756
  177. Poncin P., Proft J. Stent Tubing: Understanding the Desired Attributes. Materials & Process for Medical Devices Conference. Anaheim, 8-10 September 2003. 7p.
  178. Marti P., Lampus F., Benevento D., Setacci C. Trends in use of 3D printing in vascular surgery: a survey // Int. Angiol. Oct. 2019. 38(5). Pp. 418-424. doi: 10.23736/S0392-9590.19.04148-8. Epub 2019 Sep. 20. PMID: 31560185. doi: 10.23736/S0392-9590.19.04148-8
  179. Кудряшов А.Н., Требушат Д.В., Верин В.В., Воробьев В.Л. Современное поколение стентов с лекарственным покрытием: фокус на сироли-мус-покрытый стент «Калипсо» // Патология кровообращения и кардиохирургия. 2017. 21(1). Pp. 37-43. doi: 10.21688-1681-3472-2017-1-37-43
  180. Poncin P., Millet C., Chevy J., Proft J.L. Comparing and Optimizing Co-Cr Tubing for Stent Applications. Medical Device Materials II. Proceedings of the Materials and Processes for Medical Devices Conference - 2004. 2004. 5p
  181. Harewood F., McHugh P. Modeling of size dependent failure in cardiovascular stent struts under tension and bending // Annal. Biomed. Eng. 2007. 35(9). Pp. 1539-53. doi: 10.1007/s10439-007-9326-6
  182. . Sun F., Mantovani D., Prima F. Carbides and their role in advanced mechanical properties of L605 alloy: Implications for medical devices // Materials Science Forum Vols. 783-786. 2014. Pp. 1354-1359. doi: 10.4028/www.scientific.net/MSF.783-786.1354
  183. Jiang Y., Zhang J., Zhao W. Influence of strut cross-section of stents on local hemodynamics in stented arteries // Chinese Journal of Mechanical Engineering. 2016. Vol. 29. Pp. 624-632.
  184. Ilman K.A., Herliansyah M.K. The effect of electropolishing parameter on 316L stainless steel surface roughness for coronary stent application. Conference. 2017. 7th International Annual Engineering Seminar (InAES). doi: 10.1109/INAES.2017.8068568
  185. Sojitra P., Engineer C., Raval A. et al. Surface enhancement and characterization of L-605 cobalt alloy cardiovascular stent by novel electrochemical treatment // Artificial Organs. 2009. 23. Pp. 55-64.
  186. Han W., Fang F. Fundamental aspects and recent developments in electropolishing // International Journal of Machine Tools and Manufacture. 2019. Vol. 139. Pp. 1-23. https://doi.org/ 10.1016/j.ijmachtools.2019.01.001
  187. Palmerini T., Biondi-Zoccai G., Riva D.D., Mariani A., Sabatb M., Smits P.C., Kaiser C., D'Ascenzo F., Frati G., Mancone M., Genereux P., Stone G.W. Clinical outcomes with bioabsorbable polymer-versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis // J. Am. Coll. Cardiol. Feb. 4. 2014. 63(4). Pp. 299-307. doi: 10.1016/j.jacc.2013.09.061
  188. . Grube E., Lansky A., Hauptmann K.E., Di Mario C., Di Sciascio G., Colombo A., Silber S., Stumpf J., Reifart N., Fajadet J., Marzocchi A., Schofer J., Dumas P., Hoffmann R., Guagliumi G., Pitney M., Russell M.E. SCORE randomized trial. High-dose 7-hexanoyltaxol-eluting stent with polymer sleeves for coronary revascularization: oneyear results from the SCORE randomized trial // J. Am. Coll. Cardiol. 2004. 44(7). Pp. 1368-1372. https://doi.org/10.1016/j.jacc.2004.06.054
  189. Helmus M.N., Gibbons D.F., Cebon D. Biocompatibility: Meeting a Key Functional Requirement of Next-Generation Medical Devices Toxicologic Pathology. 2008. 36. Pp. 70-80. doi: 10.1177/0192623307310949
  190. .HuT.,YangC.,LinS.,YuQ.,WangaG. Biodegradable stents for coronary artery disease treatment: Recent advances and future perspectives // Materials Science and Engineering: C. October 2018. Vol. 91. 1. Pp. 163-178. doi: https://doi.org/10.1016/j.msec.2018.04.100
  191. Dahl J.U., Khaager P., Grube E., Gross M., Beythien C., Kromer E.P., Cattelaens N., Hamm C.W., Hoffmann R., Math T.R.D., Klues H.G. Effects of gold coating of coronary stents on neointimal proliferation following stent implantation // The American Journal of Cardiology. April 2002. Vol. 89. Iss. 7. 1. Pp. 801-805. doi: https://doi.org/10.1016/S0002-9149(02)02188-4
  192. Kastrati A., Schomig A., Dirschinger J. et al. Increased risk of restenosis after placement of gold-coated stents // Circulation. 2000. 101 (21). Pp. 24782483. doi: 10.1161/01.cir.101.21.2478
  193. Antoniucci D., Bartorelli A., Valenti R. et al. Clinical and angiographic outcome after coronary arterial stenting with the carbostent // Am. J. Cardiol. 2000. 85 (7). Pp. 821-825. doi: 10.1016/s0002-9149(99)00874-7
  194. Carrie D., Khalife K., Hamon M. et al. Initial and follow-up results of the Tenax coronary stent // J. Interv. Cardiol. 2001. 14 (1). Pp. 1-5. doi: 10.1111/j.1540-8183.2001.tb00702.x
  195. Gupta V., Fischell T.A., Aravamuthan B.R. et al. Use of Heparin-Coated Stents to Reduce Subacute Stent Thrombosis: Outcome in «Real-World» Patients // Am. J. Cardiol. 2002. 90 (Suppl 6A). 7H.
  196. Galli M., Sommariva L., Prati F. et al. Acute and mid-term results of phosphorylcholine coated stents in primary coronary stenting for acutemyocardial infarction // Catheter Cardiovasc. Interv. Jun. 2001. 53 (2). Pp. 182-187. doi: 10.1002/ccd.1145
  197. Grenadier E., Roguin A., Hertz I. et al. Stenting very small coronary narrowings (<2 mm) using the biocompatible phosphoryline-coated coronary stent // Catheter Cardiovasc. Interv. 2002. 55(3). Pp. 303308. doi: 10.1002/ccd.10130
  198. Strecker E.P., Gabelmann A., Boos I., Lucas C., Xu Z., Haberstroh J., Freudenberg N., Stricker H., Langer M., Betz E. Effect on intimal hyperplasia of dexamethasone released from coated metal stents compared with non-coated stents in canine femoral arteries // Cardiovascular and Interventional Radiology. 1998. Vol. 21. Pp. 487-496. doi: 10.1007/ s002709900309
  199. Silber S., Colombo A., Banning A.P. et al. Final 5-Year Results of the TAXUS II Trial A Randomized Study to Assess the Effectiveness of Slow- and Moderate-Release Polymer-Based Paclitaxel-Eluting Stents for De Novo Coronary Artery Lesions // Circulation. Oct. 13. 2009. 120 (15). Pp. 1498-1504. doi: 10.1161/CIRCULATIONAHA.109.849877
  200. Morice M.C., Serruys P.W., Sousa J.E. et al. RAVEL Study Group. A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization // N. Engl. J. Med. Jun 6. 2002. 346(23). Pp. 1773-1780. doi: 10.1056/ NEJMoa012843
  201. Virmani R., Guagliumi G., Farb A. et al. Localized Hypersensitivity and Late Coronary Thrombosis Secondary toa Sirolimus-Eluting Stent Should We Be Cautious? // Circulation. Feb 17. 2004. 109 (6). Pp. 701-705. doi: 10.1161/01.CIR.0000116202.41966.D4
  202. Schwartz R.S., Chronos N.A., Virmani R. Preclinical restenosis models and drug-eluting stents: still important, still much to learn // J. Am. Coll. Cardiol. 2004. 44. Pp. 1373-1385. doi: 10.1016/j. jacc.2004.04.060
  203. Hwang C.W., Wu D., Edelman E.R. Physiologic transport forces govern drug distribution for stent-based delivery // Circulation. 2001. 104. Pp 600-605. doi: 10.1161/h c3101.092214
  204. Serruys P.W., Sianos G., Abizaid A. et al. The effect of variable dose and release kinetics on neointimal hyperplasia using a novel paclitaxel-eluting stent platform: the Paclitaxel In-Stent Controlled Elution Study (PISCES) // J. Am. Coll. Cardiol. 2005. 46. Pp. 253260. https://doi.org/10.1016/jjacc.2005.03.069
  205. Carter A.J., Aggarwal M., Kopia G.A. et al. Long-term effects of polymerbased, slow-release, sirolimus-eluting stents in a porcine coronary model // Cardiovasc. Res. 2004. 63. Pp. 617-624. doi: 10.1016/j. cardiores.2004.04.029
  206. Tesfamariam B. Local vascular toxicokinetics of stent-based drug delivery // Toxicol Lett. 2007. 168. Pp. 93-102. doi: 10.1016/j.toxlet.2006.11.013
  207. Ranade S.V., Miller K.M., Richard R.E. et al. Physical characterization of controlled release of paclitaxel from the TAXUS Express drug eluting stent // J. Biomed. Mater. Res. 2004. 71A. Pp. 625-634. doi: 10.1002/jbm.a.30188
  208. Bertrand O.F., Sipehia R., Mongrain R. et al. Biocompatibility aspects of new stent technology // J. Am. Coll. Cardiol. 1998. 32. Pp. 562-571. doi: 10.1016/ s0735-1097(98)00289-7
  209. VanderGiessen W.J.,LincoffA.M.,SchwartzR.S. et al. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries // Circulation. 1996. 94. Pp. 1690-1697. doi: 10.1161/01.cir.94.7.1690
  210. Tesfamariam B. Drug Release Kinetics From Stent Device-Based Delivery Systems // J. Cardiovasc. Pharmacol. TM. 2008. 51. Pp. 118-125 doi: 10.1097/ FJC.0b013e318158540f
  211. Taylor M.S., Daniels A.U., Andriano K.P. et al. Six bioabsorbable polymers: in vitro acute toxicity of accumulated degradation products // J. Appl. Biomater. 1994. 5. Pp. 151-157. doi: 10.1002/ jab.770050208
  212. . Lewis A.L., Willis S.L., Small S.A. et al. Drug loading and elution from a phosphorylcholine polymer-coated coronary stent does not affect longterm stability of the coating in vivo // Biomed. Mater. Eng. 2004. 14. Pp. 355-370.
  213. Shastri V.P. Non-degradable biocompatible polymers in medicine: past, present and future // Curr. Pharm. Biotechnol. 2003. 4. Pp. 331-337. doi: 10.2174/1389201033489694
  214. Virmani R., Guagliumi C., Farb A. et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: Should we be cautious? // Circulation. 2004. 109. Pp. 701-705. doi: 10.1161/01.CIR.0000116202.41966.D4
  215. Amidon G.L., Lennernas, H., Shah V.P. et al. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability // Pharm. Res. 1995. 12. Pp. 413-420.
  216. Royce A., Li S., Weaver M. et al. In vivo and in vitro evaluation of three controlled release principles of 6-N-cyclohexyl-2#-O-methyladenosine // J. Control. Release. 2004. 97. Pp. 79-90. doi: 10.1016/j. jconrel.2004.02.016
  217. Skelly J.P., Shiu G.F. In vitro/in vivo correlations in biopharmaceutics: scientific and regulatory implications // Eur. J. Drug. Metab. Pharmacokinet. 1993. 18. Pp7 121-129. doi: 10.1007/BF03220015
  218. Bhattacharya P., Neogi S. Techniques for Deposition of Coatings with Enhanced Adhesion to Bio-Implants. Chapter in: Adhesion in Pharmaceutical, Biomedical and Dental Fields. Scrivener Publishing LLC. 2017. Pp. 233-254. (2017). DOI: 10.1002/9781119323716.ch11
  219. Barreras F., Amaveda H., Lozano A. Transient High-Frequency Ultrasonic Water Atomization. Experiments in Fluids. 33(3). Pp. 405-413. doi:10.1007/ s00348-002-0456-1
  220. Kondoh J. Experimental consideration of high frequency ultrasonic atomization using SAW devices. Ultrasonics Symposium (IUS): IEEE International. 2009. Pp. 1636-1639. doi: 10.1109/ULTSYM.2009.5442064
  221. Экнадиосянц О.К. «О распылении жидкости низкочастотными ультразвуковыми колебаниями» // Акустический журнал. 1966. 12. 1. C. 127-129.
  222. Brochure. Optical Stent Inspection Qsix [Электронный ресурс] // Sen-sofar Medical. URL: https:// www.sensofa r.com/wp-content/uploads/2016/01/ Brochure-Q-six-v5-EN-web.pdf (дата обращения 04.09.2022).
  223. ISO 25539-2:2012 Cardiovascular implants — Endovascular devices — Part 2: Vascular stents. https://www.iso.org/ru/standard/60604.html (дата обращения 04.09.2022).
  224. Raja Y., Routledge H.C., Doshi S.N. A Non-compliant, High Pressure Balloon to Manage Undilatable Coronary Lesions // Catheterization and Cardiovascular Interventions. 2010. 75. Pp. 1067-1073. doi: 10.1002/ccd.22430
  225. Brodie B.R. Adjunctive Balloon Postdilatation after Stent Deployment: Is It Still Necessary with Drug-Eluting Stents? // Journal of Interventional Cardiology. 2006. Vol. 19. No. 1. doi: 10.1111/j.1540-8183.2006.00103.x
  226. Fedel M., Tessarolo F., Ferrari P., Losche C., Ghassemieh N., Guarrera G.M., Nollo G. Functional Proerties and Performance of New and Reprocessed Coronary Angioplasty Balloon Catheters // Journal of Biomedical Materials Research. Part B: Applied Biomaterials. Published online 27 February 2006 in Wiley InterScience (www.interscience.wiley.com). doi: 10.1002/jbmb
  227. Jin G., Hua W., Wang K. et al. Theoretical and experimental study on threelayered polymeric balloon catheter processing // Polym. Eng. Sci. 2020. e25550. doi: https://doi.org/10.1002/pen.25550
  228. ISO 10993-1:2018 Biological evaluation of medical devices — Part 1: Evaluation and testing within a risk management process. https://www.iso.org/ru/ standard/68936.html (дата обращения 04.09.2022)
  229. ISO 10555-3:2013 Intravascular catheters — Sterile and single-use catheters — Part 3: Central venous catheters. https://www.iso.org/ standard/57382.html (дата обращения 04.09.2022)
  230. Dumoulin C., Cochelin B. Mechanical behaviour modelling of balloon-expandable stents // Journal of Biomechanics. 2000. 33. Pp.1461-1470. doi: 10.1016/s0021-9290(00)00098-1
  231. Migliavacca F., Petrini L., Colombo M., Auricchio F., Pietrabissa R. Mechanical behavior of coronary stents investigated through the finite element method // Journal of Biomechanics. 2002. 35. Pp. 803-811. doi: 10.1016/s0021-9290(02)00033-7 35. Pp. 803-811. doi: 10.1016/s0021-9290(02)00033-7
  232. HolzapfelG.A., Stadler M., Gasser T.C. Changes in the mechanical environment of stenotic arteries during interaction with stents: computational assessment of parametric stent designs // Journal of Biomechanical Engineering. 2005. 127. Pp. 166-180. doi: 10.1115/1.1835362
  233. De Beule M., van Impe R., Verhegghe B., Segers P., Verdonck P. Finite element analysis and stent design: reduction of dogboning // Technology and Health Care. 2006. 14. Pp. 233-241.
  234. Hall G.J., Kasper E.P. Comparison of element technologies for modelling stent expansion // Journal of Biomechanical Engineering. 2006. 128. Pp. 751756. doi: 10.1115/1.2264382
  235. Takashima K., Kitou T., Mori K., Ikeuchi K. Simulation and experimental observation of contact conditions between stents and artery models // Medical Engineering and Physics. 2007. 29. Pp. 326335. doi: 10.1016/j.medengphy.2006.04.003
  236. Wu W., Wang W.Q., Yang D.Z., Qi M. Stent expansion in curved vessel and their interactions: a finite element analysis // Journal of Biomechanics. 2007. 40. 2580. doi: 10.1016/j.jbiomech.2006.11.009
  237. Wang W.Q., Liang D.K., Yang D.Z., Qi M. Analysis of the transient expansion behavior and design optimization of coronary stents by finite element method // Journal of Biomechanics. 2006. 39. Pp. 21-32. doi: 10.1016/j.jbiomech.2004.11.003
  238. Liang D.K., Yang D.Z., Qi M., Wang W.Q. Finite element analysis of the implantation of a balloon-expandable stent in a stenosed artery // International Journal of Cardiology. 2005. 104. Pp. 314-318. doi: 10.1016/j.ijcard.2004.12.033
  239. Raamachandran J., Jayavenkateshwaran K. Modeling of stents exhibiting negative Poisson's ratio effect // Computer Methods in Biomechanics and Biomedical Engineering. 2007. 10. Pp. 245-255. doi: 10.1080/10255840701198004
  240. De Beule M., Mortier P., CarlierS.G., Verhegghe B., van Impe R., Verdonck P. Realistic finite element-based stent design: the impact of balloon folding // Journal of Biomechanics, in press. 2007. doi: 10.1016/j. jbiomech.2007.08.014
  241. Ju F., Xia Z., Sasaki K. On the finite element modelling of balloon-expandable stents // Journal of the Mechanical Behavior of Biomedical Materials. 2008. 1. Pp 86-95. doi: 10.1016/j.jmbbm.2007.07.002
  242. De Beule M., Mortier P., CarlierS.G., Verhegghe B., Impe R.V., Verdonck P. Realistic finite element-based stent design: The impact of balloon folding // J. Biomech. 2008. 41. Pp. 383-389. doi: 10.1016/j. jbiomech.2007.08.014
  243. Chua S.N.D., McDonald B.J., Hashimi M.S.J. Finite element simulation of stent and balloon interaction // J. Mater. Process. Tech. 143-144. Pp. 591597. https://doi.org/10.1016/S0924-0136(03)00435-7
  244. ISO 14644-1:2015 Cleanrooms and associated controlled environments — Part 1: Classification of air cleanliness by particle concentration. https://www. iso.org/ru/standard/53394.html (дата обращения 04.09.2022).
  245. ISO 13485:2016 Medical devices — Quality management systems — Requirements for regulatory purposes. https://www.iso.org/ru/standard/59752. html (дата обращения 04.09.2022).
  246. EU Medical Device Regulation. tuv-sud.com (дата обращения 04.09.2022).
  247. Сайт Росздравнадзора. https://www. roszdravnadzor.gov.ru/medproducts/documents/ b40 (дата обращения 04.09.2022).
  248. Deming W. E.The New Economics for Industry, Government, and Education. Boston: Ma: MIT Press, 1993. P. 132.
  249. Pietzsch J.B., Shluzas L.A., Pate-Cornell M.E, Yock P.G, Linehan J.H. Stage-Gate Process for the Development of Medical Devices // Journal of medical devices. 2009. doi:10.1115/1.3148836

Отзывы

Оставить отзыв +
Ваш браузер устарел и не обеспечивает полноценную и безопасную работу с сайтом.
Установите актуальную версию вашего браузера или одну из современных альтернатив.